Fusion Antibodies Statements
FA
Data from Fusion Antibodies`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
GBP - British pound
Last reporting period:
31 Mar, 2024
Next reporting period:
27 Sep, 2024
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
02 Dec, 2024
Fusion Antibodies Income Statement
B
M
GBP (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
0.595
10 %
100
0.556
93.4
0.039
146.4 %
6.6
—
0
0.912
153.3
0.908
-32 %
152.6
-0.869
38.8 %
-146.05
-0.001
-0.2
0.001
0.2
-0.869
38.8 %
-146.05
—
0
-0.869
36 %
-146.05
-0.013
64.615
0.541
-47.9 %
100
0.625
115.5
-0.084
-154.5 %
-15.5
0.182
33.6
1.153
213.1
1.335
-14.9 %
246.8
-1.419
11.4 %
-262.3
-0.001
-0.2
—
0
-1.42
11.1 %
-262.5
-0.063
-11.6
-1.357
8.3 %
-250.8
-0.029
46.497
1.038
-44.3 %
100
1.071
103.2
-0.033
-105.4 %
-3.2
0.425
40.9
1.147
110.5
1.569
-15.8 %
151.2
-1.602
-27.5 %
-154.3
0.005
0.5
—
0
-1.597
-26.5 %
-153.9
-0.117
-11.3
-1.48
-32.6 %
-142.6
-0.057
26.015
1.863
-21 %
100
1.256
67.4
0.607
-52 %
32.6
0.452
24.3
1.419
76.2
1.863
-4 %
100
-1.256
-85.8 %
-67.4
-0.006
-0.3
—
0
-1.262
-85 %
-67.7
-0.146
-7.8
-1.116
-81.2 %
-59.9
-0.043
26.015
2.358
-3.4 %
100
1.093
46.4
1.265
5.3 %
53.6
0.275
11.7
1.65
70
1.941
4.9 %
82.3
-0.676
-4.2 %
-28.7
-0.006
-0.3
—
0
-0.682
-4.8 %
-28.9
-0.066
-2.8
-0.616
-5.5 %
-26.1
-0.024
26.07
2.441
8 %
100
1.24
50.8
1.201
4.3 %
49.2
0.424
17.4
1.472
60.3
1.85
0.7 %
75.8
-0.649
5.4 %
-26.6
-0.002
-0.08
—
0
-0.651
5.9 %
-26.7
-0.067
-2.7
-0.584
75.9 %
-23.9
-0.023
25.822
2.26
18.6 %
100
1.109
49.1
1.151
31.8 %
50.9
0.342
15.1
1.646
72.8
1.837
27.9 %
81.3
-0.686
-21.8 %
-30.4
-0.006
-0.3
—
0
-0.692
-21 %
-30.6
1.736
76.8
-2.428
-415.5 %
-107.4
-0.093
26.042
1.905
-11.1 %
100
1.032
54.2
0.873
-15.5 %
45.8
0.271
14.2
1.208
63.4
1.436
-2.7 %
75.4
-0.563
-27.1 %
-29.6
-0.009
-0.5
—
0
-0.572
-26.5 %
-30.03
-0.101
-5.3
-0.471
-110.3 %
-24.7
-0.019
24.875
2.142
22.2 %
100
1.109
51.8
1.033
39.8 %
48.2
—
0
1.479
69
1.476
8.9 %
68.9
-0.443
28.1 %
-20.7
-0.009
-0.4
—
0
-0.452
27.2 %
-21.1
-0.228
-10.6
-0.224
52.6 %
-10.5
-0.01
22.091
1.753
15.1 %
100
1.014
57.8
0.739
6.9 %
42.2
—
0
1.408
80.3
1.355
3.7 %
77.3
-0.616
0 %
-35.1
-0.005
-0.3
—
0
-0.621
-1.4 %
-35.4
-0.148
-8.4
-0.473
9.4 %
-27
-0.021
22.091
1.523
131.4 %
100
0.832
54.6
0.691
511.7 %
45.4
—
0
1.336
87.7
1.307
30 %
85.8
-0.616
31 %
-40.4
0.004
0.2
—
0
-0.613
31 %
-40.2
-0.09
-5.9
-0.522
29.6 %
-34.3
-0.024
22.091
0.658
-48.4 %
100
0.545
82.8
0.113
-83 %
17.2
—
0
1.063
161.5
1.005
-18.2 %
152.7
-0.892
-58.7 %
-135.5
0.005
0.8
—
0
-0.887
-58.2 %
-134.8
-0.145
-22.06
-0.742
-39.1 %
-112.7
-0.034
22.091
1.277
-9.7 %
100
0.61
47.8
0.666
-18.5 %
52.2
—
0
1.254
98.2
1.229
27.3 %
96.2
-0.562
-279.6 %
-44.05
0.002
0.1
—
0
-0.561
-272.6 %
-43.9
-0.027
-2.1
-0.534
-220.7 %
-41.8
-0.053
10.143
1.414
30.9 %
0.597
0.817
40.9 %
—
0.995
0.965
82.1 %
-0.148
-346.9 %
-0.002
—
-0.151
-350.9 %
0.016
-0.166
-308 %
-0.008
22.091
1.08
30.1 %
0.5
0.58
52.6 %
—
0.57
0.53
71 %
0.06
-14.3 %
—
-0.05
0.06
-14.3 %
-0.02
0.08
100 %
—
22.09
0.83
—
0.45
0.38
—
—
0.31
0.31
—
0.07
—
—
—
0.07
—
0.03
0.04
—
—
22.09